Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business
Lifecore Biomedical Inc LFCR
$4.20
▼ -2.10%
($-0.09)
⬇️ Below Yest. Low
Open
$4.27
Prev Close
$4.29
Day Range
$4.12 – $4.39
52W Range
$3.63 – $8.98
Market Cap
$158.98M
Beta
1.09
EPS (TTM)
$-1.31
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1996-02-15 |
| Shares Out. | 37,510,000 |
| Website | lifecore.com/ ↗ |
| Phone | 18009279800 |
| Employees | 382 |
| Revenue | $34.2M |
| Gross Profit | $12.1M |
| Net Income | -$6.2M |
| Total Assets | $229.5M |
| Total Liabilities | $213.4M |
| Equity | -$34.1M |
About Lifecore Biomedical Inc
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Lifecore Biomedical Inc is a publicly traded company under the ticker symbol LFCR on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-09-01)